Clinical evaluation and follow-up outcome of presurgical plan by Dextroscope: a prospective controlled study in patients with skull base tumors

De L. Yang PhD, MD, Qi W. Xu PhD, MD, Xiao M. Che PhD, MD, Jin S. Wu PhD, MD, Bin Sun PhD, MD
{"title":"Clinical evaluation and follow-up outcome of presurgical plan by Dextroscope: a prospective controlled study in patients with skull base tumors","authors":"De L. Yang PhD, MD,&nbsp;Qi W. Xu PhD, MD,&nbsp;Xiao M. Che PhD, MD,&nbsp;Jin S. Wu PhD, MD,&nbsp;Bin Sun PhD, MD","doi":"10.1016/j.surneu.2009.07.040","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Patient-specific approach design, comprehensive evaluation on perioperative data, and follow-up of postoperative life quality (KPS) were carried out to evaluate the application of VR technology of Dextroscope in procedures of patients with skull base tumors.</p></div><div><h3>Methods</h3><p>Eighty-four patients with skull base tumors involved in this research were randomized into 2 groups (test group and control group), each with 42 patients. Before operation, image data such as MR, MRA, or CTA of head were collected and imported into the Dextroscope workstation. The detailed preoperative plans were made in the test group, but no Dextroscope plans in control group. The resection rate of tumors, preoperative evaluation including the duration of operation, total blood loss, the postoperative LOS, the number of cases with cerebrovascular injury complications in operation, and postoperative KPS of patients on discharge and the sixth month follow-up in the 2 groups were recorded and compared.</p></div><div><h3>Results</h3><p>The total resection rate of tumors was 83.33% in test group and 71.42% in the control group (<em>P</em> &gt; .05). The total resection rate of meningioma was 86.67% in test group and 76.47% in control group. The total resection rates of trigeminal Schwannoma in the 2 groups were all 100% (<em>P</em> &gt; .05). The duration of operation and the postoperative LOS of each patient were 5.25 ± 0.64 hours and 8.50 ± 1.10 days in the test group and 7.36 ± 0.87 hours and 12.50 ± 1.52 days in the control group, respectively (<em>P</em> &lt; .05). Total blood loss of each patient was 456.75 ± 55.76 mL in the test group and 523.85 ± 66.78 mL in the control group (<em>P</em> &gt; 05). There were 3 cases with complications of cerebral vessels injury in the test group and 7 cases in the control group (<em>P</em> &lt; .05). During follow-up, KPS of patients in the test group on discharge (85.75 ± 9.68) was significantly superior to that in the control group (81.66 ± 9.24; <em>P</em> &lt; .05). The KPS of patients on the sixth-month follow-up in the test group was 92.35 ± 9.95, which was significantly superior to that in the control group (85.6 ± 9.34; <em>P</em> &lt; .05). Karnofsky performance scores of patients in the test group improved significantly from discharge to the sixth month after procedure (<em>P</em> &lt; .05), whereas there were adverse results in the test group (<em>P</em> &lt; .05). The 2 cases with CSF leakage were cured completely.</p></div><div><h3>Conclusion</h3><p>The preoperative plans with VR technology in patients with skull base tumor or CSF leakage operations can help certain the diagnosis, individually locate the position of skull base lesions, and design patient-specific approach, which also facilitate to shorten operation duration and the postoperative LOS, reduce total blood loss and injury of vessels in operation, and improve the postoperative KPS.</p></div>","PeriodicalId":22153,"journal":{"name":"Surgical Neurology","volume":"72 6","pages":"Pages 682-689"},"PeriodicalIF":0.0000,"publicationDate":"2009-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.surneu.2009.07.040","citationCount":"33","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Neurology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090301909006569","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 33

Abstract

Background

Patient-specific approach design, comprehensive evaluation on perioperative data, and follow-up of postoperative life quality (KPS) were carried out to evaluate the application of VR technology of Dextroscope in procedures of patients with skull base tumors.

Methods

Eighty-four patients with skull base tumors involved in this research were randomized into 2 groups (test group and control group), each with 42 patients. Before operation, image data such as MR, MRA, or CTA of head were collected and imported into the Dextroscope workstation. The detailed preoperative plans were made in the test group, but no Dextroscope plans in control group. The resection rate of tumors, preoperative evaluation including the duration of operation, total blood loss, the postoperative LOS, the number of cases with cerebrovascular injury complications in operation, and postoperative KPS of patients on discharge and the sixth month follow-up in the 2 groups were recorded and compared.

Results

The total resection rate of tumors was 83.33% in test group and 71.42% in the control group (P > .05). The total resection rate of meningioma was 86.67% in test group and 76.47% in control group. The total resection rates of trigeminal Schwannoma in the 2 groups were all 100% (P > .05). The duration of operation and the postoperative LOS of each patient were 5.25 ± 0.64 hours and 8.50 ± 1.10 days in the test group and 7.36 ± 0.87 hours and 12.50 ± 1.52 days in the control group, respectively (P < .05). Total blood loss of each patient was 456.75 ± 55.76 mL in the test group and 523.85 ± 66.78 mL in the control group (P > 05). There were 3 cases with complications of cerebral vessels injury in the test group and 7 cases in the control group (P < .05). During follow-up, KPS of patients in the test group on discharge (85.75 ± 9.68) was significantly superior to that in the control group (81.66 ± 9.24; P < .05). The KPS of patients on the sixth-month follow-up in the test group was 92.35 ± 9.95, which was significantly superior to that in the control group (85.6 ± 9.34; P < .05). Karnofsky performance scores of patients in the test group improved significantly from discharge to the sixth month after procedure (P < .05), whereas there were adverse results in the test group (P < .05). The 2 cases with CSF leakage were cured completely.

Conclusion

The preoperative plans with VR technology in patients with skull base tumor or CSF leakage operations can help certain the diagnosis, individually locate the position of skull base lesions, and design patient-specific approach, which also facilitate to shorten operation duration and the postoperative LOS, reduce total blood loss and injury of vessels in operation, and improve the postoperative KPS.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
右旋镜手术方案在颅底肿瘤患者中的临床评价及随访结果:一项前瞻性对照研究
背景:通过患者特异性入路设计、围手术期资料综合评价、术后生活质量随访等方法评价VR技术在颅底肿瘤患者手术中的应用。方法84例颅底肿瘤患者随机分为2组(试验组和对照组),每组42例。术前采集头部MR、MRA、CTA等图像数据,导入Dextroscope工作站。实验组制定了详细的术前计划,对照组未制定Dextroscope计划。记录并比较两组患者的肿瘤切除率、术前评价包括手术时间、总出血量、术后LOS、术中脑血管损伤并发症例数、出院时及随访6个月后KPS。结果试验组肿瘤总切除率为83.33%,对照组为71.42% (P >. 05)。实验组脑膜瘤总切除率为86.67%,对照组为76.47%。两组三叉神经鞘瘤总切除率均为100% (P >. 05)。实验组患者手术时间5.25±0.64小时,术后LOS 8.50±1.10天;对照组患者手术时间7.36±0.87小时,术后LOS 12.50±1.52天(P <. 05)。试验组患者总出血量456.75±55.76 mL,对照组患者总出血量523.85±66.78 mL (P >05). 实验组出现脑血管损伤并发症3例,对照组出现脑血管损伤并发症7例(P <. 05)。随访中,实验组患者出院时KPS(85.75±9.68)明显优于对照组(81.66±9.24);P & lt;. 05)。试验组患者随访6个月KPS为92.35±9.95,显著优于对照组(85.6±9.34;P & lt;. 05)。试验组患者Karnofsky评分从出院到手术后6个月显著提高(P <0.05),而试验组有不良结果(P <. 05)。2例脑脊液漏完全治愈。结论颅底肿瘤或脑脊液漏手术患者采用VR技术进行术前规划有助于明确诊断,个体化定位颅底病变位置,设计个体化入路,有利于缩短手术时间和术后LOS,减少术中总出血量和血管损伤,提高术后KPS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Surgical Neurology
Surgical Neurology 医学-临床神经学
自引率
0.00%
发文量
0
期刊最新文献
Cardiac ventricular myosin and slow skeletal myosin exhibit dissimilar chemomechanical properties despite bearing the same myosin heavy chain isoform. Moyamoya disease. PNIPAAM modified mesoporous hydroxyapatite for sustained osteogenic drug release and promoting cell attachment. Biomedical research Editorial Board
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1